Golf, that may be a remaining multibillion dollar question? If one Avenue looks really good, but the other Avenue does not in a combined fashion, would the FDA really stop something very promising in a specific safe and effective combination?

 Not feeling overly confident in the short term this morning, but there are a lot of data to review, and questions and what if’s to be studied and answered. 

 The knee-jerk this week could be an opportunity, but it could be throwing more good money after bad money to though 

The next six weeks are going to be even more grinding than the past six weeks